{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:34:18Z","timestamp":1790940858079,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.peptides.2010.04.018","type":"journal-article","created":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T08:51:10Z","timestamp":1272703870000},"page":"1617-1624","source":"Crossref","is-referenced-by-count":23,"title":["Synthesis and biological evaluation of novel peripherally active morphiceptin analogs"],"prefix":"10.1016","volume":"31","author":[{"given":"Katarzyna","family":"Gach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"do-Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Fichna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Storr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Delbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geza","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Janecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2010.04.018_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2165\/00003495-200666080-00004","article-title":"Irritable bowel syndrome: recent and novel therapeutic approaches","volume":"66","author":"Andresen","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.peptides.2010.04.018_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF02605761","article-title":"Segmental colonic transit time","volume":"24","author":"Arhan","year":"1981","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.peptides.2010.04.018_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.pa.23.040183.001431","article-title":"Pharmacology of antidiarrheal drugs","volume":"23","author":"Awouters","year":"1983","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.peptides.2010.04.018_bib4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/jn\/109.9.1592","article-title":"Sites of organic acid production and patterns of digesta movement in the gastrointestinal tract of dogs","volume":"109","author":"Banta","year":"1979","journal-title":"J Nutr"},{"key":"10.1016\/j.peptides.2010.04.018_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.2042-7158.1996.tb07112.x","article-title":"The blood\u2013brain barrier: principles for targeting peptides and drugs to the central nervous system","volume":"48","author":"Begley","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.peptides.2010.04.018_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0169-409X(00)00139-3","article-title":"Delivery of peptides and proteins through the blood\u2013brain barrier","volume":"46","author":"Bickel","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.peptides.2010.04.018_bib7","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1021\/js960067d","article-title":"How structural features influence the biomembrane permeability of peptides","volume":"85","author":"Burton","year":"1996","journal-title":"J Pharm Sci"},{"issue":"1 Suppl.","key":"10.1016\/j.peptides.2010.04.018_bib8","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/00004836-200207001-00011","article-title":"Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds","volume":"35","author":"Callahan","year":"2002","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl. 4","key":"10.1016\/j.peptides.2010.04.018_bib9","first-page":"56","article-title":"Visceral pain\u2014central sensitisation","volume":"47","author":"Cervero","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.peptides.2010.04.018_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.6259732","article-title":"(NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors","volume":"212","author":"Chang","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.peptides.2010.04.018_bib11","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1016\/S0021-9258(17)39296-7","article-title":"Isolation of a specific mu-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins","volume":"260","author":"Chang","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2010.04.018_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0167-4838(97)00134-9","article-title":"Proline specific peptidases","volume":"1343","author":"Cunningham","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.peptides.2010.04.018_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.43.100901.140204","article-title":"The role of drug transporters at the blood\u2013brain barrier","volume":"43","author":"De Boer","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.peptides.2010.04.018_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0163-7258(98)00021-7","article-title":"Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management","volume":"80","author":"De Ponti","year":"1998","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.peptides.2010.04.018_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(80)90377-5","article-title":"Release of prostaglandins E and F in an algogenic reaction and its inhibition","volume":"61","author":"Deraedt","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2010.04.018_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3565(25)05180-8","article-title":"Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines","volume":"107","author":"Eddy","year":"1953","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.04.018_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.peptides.2007.12.005","article-title":"[Dmt1, d-1-Nal3]morphiceptin, a novel opioid peptide analog with high analgesic activity","volume":"29","author":"Fichna","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.018_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/jm060998u","article-title":"Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), d-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), d-2-Nal(4)]endomorphin-2 (Antanal-2)","volume":"50","author":"Fichna","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2010.04.018_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbrc.2004.05.202","article-title":"Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs","volume":"320","author":"Fichna","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2010.04.018_bib20","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1365-2982.2009.01369.x","article-title":"Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors","volume":"21","author":"Fichna","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.peptides.2010.04.018_bib21","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1208\/aapsj070482","article-title":"Transport systems for opioid peptides in mammalian tissues","volume":"7","author":"Ganapathy","year":"2005","journal-title":"AAPS J"},{"key":"10.1016\/j.peptides.2010.04.018_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.peptides.2010.04.018_bib23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1021\/jm00082a008","article-title":"Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,d-Pen2,d-Pen5]enkephalin","volume":"35","author":"Hansen","year":"1992","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2010.04.018_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/med.2610090306","article-title":"Recent developments in the design of receptor specific opioid peptides","volume":"9","author":"Hruby","year":"1989","journal-title":"Med Res Rev"},{"key":"10.1016\/j.peptides.2010.04.018_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568026043451618","article-title":"Opioid receptors and their ligands","volume":"4","author":"Janecka","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.peptides.2010.04.018_bib26","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.peptides.2008.07.015","article-title":"Enzymatic degradation of endomorphins","volume":"29","author":"Janecka","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.018_bib27","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2174\/138161208784705423","article-title":"Blood\u2013brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides","volume":"14","author":"Kastin","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.peptides.2010.04.018_bib28","first-page":"412","article-title":"Acetic acid for analgesic screening","volume":"18","author":"Koster","year":"1959","journal-title":"Fed Proc"},{"key":"10.1016\/j.peptides.2010.04.018_bib29","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1021\/bi00211a029","article-title":"Comparison of the membrane-bound states of two structurally similar delta-selective opioid peptides by transferred nuclear Overhauser effect spectroscopy and molecular modeling","volume":"32","author":"Matsunaga","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.peptides.2010.04.018_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-3011.1981.tb01993.x","article-title":"Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phyllomedusa sauvagei","volume":"17","author":"Montecucchi","year":"1981","journal-title":"Int J Pept Protein Res"},{"key":"10.1016\/j.peptides.2010.04.018_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(96)00403-7","article-title":"Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice","volume":"311","author":"Nagakura","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2010.04.018_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3109\/13550289909021285","article-title":"Blood\u2013brain barrier biology and methodology","volume":"5","author":"Pardridge","year":"1999","journal-title":"J Neurovirol"},{"key":"10.1016\/j.peptides.2010.04.018_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1023\/A:1012040425146","article-title":"Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway","volume":"14","author":"Pauletti","year":"1997","journal-title":"Pharm Res"},{"key":"10.1016\/j.peptides.2010.04.018_bib34","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.bmc.2009.04.046","article-title":"Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2","volume":"17","author":"Perlikowska","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.peptides.2010.04.018_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0005-2736(92)90083-X","article-title":"Opioid peptide interactions with lipid bilayer membranes","volume":"1109","author":"Ramaswami","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.peptides.2010.04.018_bib36","series-title":"Peptides","author":"Sacaguchi","year":"1987"},{"key":"10.1016\/j.peptides.2010.04.018_bib37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/jm00123a035","article-title":"Dermorphin analogues carrying an increased positive net charge in their \u201cmessage\u201d domain display extremely high mu opioid receptor selectivity","volume":"32","author":"Schiller","year":"1989","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2010.04.018_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF02443471","article-title":"Conformationaly constrained opioid peptide analogs with novel activity profiles","volume":"5","author":"Schiller","year":"1998","journal-title":"Lett Pept Sci"},{"key":"10.1016\/j.peptides.2010.04.018_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(25)23272-4","article-title":"Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation","volume":"249","author":"Shook","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.04.018_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1461-5347(00)00258-3","article-title":"Brain drug delivery technologies: novel approaches for transporting therapeutics","volume":"3","author":"Temsamani","year":"2000","journal-title":"Pharm Sci Technol Today"},{"key":"10.1016\/j.peptides.2010.04.018_bib41","first-page":"G81","article-title":"Genetic evidence for role of DPP IV in intestinal hydrolysis and assimilation of prolyl peptides","volume":"265","author":"Tiruppathi","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2010.04.018_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2010.03.029","article-title":"Analytical characterization and comparison of the blood\u2013brain barrier permeability of eight opioid peptides","author":"Van Dorpe","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.018_bib43","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/S0960-894X(98)00472-7","article-title":"Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore models","volume":"8","author":"Wang","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.peptides.2010.04.018_bib44","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0196-9781(01)00537-X","article-title":"Peptide drug modifications to enhance bioavailability and blood\u2013brain barrier permeability","volume":"22","author":"Witt","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.018_bib45","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/jm00058a007","article-title":"A topochemical approach to explain morphiceptin bioactivity","volume":"36","author":"Yamazaki","year":"1993","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2010.04.018_bib46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the mu-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110001725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110001725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:55:05Z","timestamp":1740056105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978110001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0196978110001725"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2010.04.018","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}